When is a surgical prostheses a suboptimal solution?
Prof. Torsten Hanke
Aortic Highlights, 2024
Prof. Patrick Klein
Aortic Highlights 2024
Tom Nguyen
Prof. Bleiziffer
Aortic Highlights course, 2023
Prof. Treede
Aortic Highlights course, 2023
Dr. Vitanova
Aortic Highlights course, 2023
Prof. Kalavrouziotis
Edwards Lifesciences at EACTS 2022: State of the art in the treatment of aortic valve regurgitation in young patients
Prof. Augusto D’Onofrio
MVT Aortic 2022, vol.1
– Not only about hemodynamics, this lecture provides comparisons among three bioprostheses
– Similar clinical outcomes, better hemodynamic results, and shorter ICU stays for rapid deployment valves… but newer bioprosthesis tissue technology may raise the bar even higher
Prof. Marco Di Eusanio
MVT Aortic 2022, vol.1
– Minimally invasive: much more than just a small cut
– Already achieved a low mortality rate? Set new goals for new targets related to patient quality of life.
– Always consider… Do you need to be cautious with the sternum? Is the patient obese? Are you an experienced surgeon? Don’t forget to perform an Angio CT scan.
Prof. Michael Borger
MVT Aortic 2022, vol.1
-The “aortic size paradox”: an interesting paradox, indeed
-Length? Diameter? Which should we pay more attention to?
-Be sure to pay attention to genetics, biomarkers, abnormal flow, other risk factors, and more
Prof. Marco Di Eusanio
MVT Aortic 2022, vol.1
Prof. Augusto d’Onofrio
MVT Aortic 2022, vol.1
– Valve-in-valve, TAVI in TAVI, SAVR after TAVI… familiarize yourself with the mid-to-long-term data for each valve type combination, and transparently inform the patients of not only the benefits but also the risks
– Even the experts say, extracting an infected TAVI is extremely difficult, so be sure to choose the original valve wisely
Prof. Bart Meuris
MVT Aortic 2022, vol.1
- Shorter hospital stays, less anticoagulation, long-term financial savings? Hear about the data of an expert’s personal experience.
- With advanced anti-calcification treatment, the future of bioprostheses is promising not only for patient outcomes, but even from a financial perspective
Dr. Douglas Johnston
STS annual meeting 202
Insights from INDURE registry
Prof. Ruggero De Paulis
Virtual Industry Symposium
